Enhanced Anti-tumor Activity of iC9/CAR-19/IL-15-Transduced CB-NK Cells Combined With PD-1 Inhibitor Treatment in B-Cell Lymphoma

Yanli Lai, Lixia Sheng, Jiaping Wang, Guifang Ouyang, Shasha You, Zhouning Lin

PDF(4805 KB)
For Authors|For Editors|For Reviewers
PDF(4805 KB)
Discovery Medicine ›› 2025, Vol. 37 ›› Issue (202) : 2602-2613. DOI: 10.24976/Discov.Med.202537202.218
Article

Enhanced Anti-tumor Activity of iC9/CAR-19/IL-15-Transduced CB-NK Cells Combined With PD-1 Inhibitor Treatment in B-Cell Lymphoma

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

Highlight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2025, 37(202): 2602-2613 https://doi.org/10.24976/Discov.Med.202537202.218

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(4805 KB)

Accesses

Citation

Detail
Sections
Recommended
Follow Us on
Copyright © 2025.
By using this website, you agree to our Terms & Conditions and Privacy Policy.  
  • Disclaimer
    The statements, opinions and data contained in Discovery Medicine are solely those of the individual authors and contributors and not of the journal and the editor(s). Discovery Medicine stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

    • /

    〈 〉